The pelvic floor refers to a network of connected muscles, tissues, as well as ligaments that support the pelvic organs. Pelvic floor disorders refer to the dropping down of the urethra, rectum, or uterus often caused by the injury of ligaments or connective tissues. As such, affected women can feel pressure in the pelvis besides developing problems with bowel movements. When that occurs, a pelvic examination is usually conducted to determine the root of the problem. In other scenarios, pelvic exercises in addition to pessaries and surgeries can be administered.
Understanding the Pelvic Floor Disorders
Since many women fail to access pelvic treatment for their disorders because of the charged attached to it, different companies have come forward to support them in seeking treatment. One such company is Renovia Inc. The firm is committed to discovering as well as delivering first-range digital therapeutic in addition to diagnostic devices customized for women who have pelvic floor disorders announced the close of a donation of $42.3 million that included $32.3 million and $10 million from Series B equity. Proceeds from these donations will be utilized in supporting Renovia’s clinical trials and corporate development.
Ascension Ventures chaired the Series B Project for financing. Other participants include Longwood Fund, Cormorant Asset Management, and Western Technology. Moreover, Marc Beer, the co-founder of Renovia was part of the program. He said that his organization was proud to be associated with the fundraiser since it would be channeled to the betterment of women’s reproductive health. He also added that the mix of capital ventures would help improve the chances of diagnosing and treating women affected by pelvic floor disorders. Besides, the partners are aligned with Renovia’s commercial vision.
Beer also said that by combining the firm’s innovative sensor technologies with innovative platforms of digital health, clients would be able to access valuable data regarding new treatment options thereby disseminating information on pelvic floor disorders. Besides, the funding recognizes the value of innovative digital treatment.
Marc Beer’s Profile
Marc Beer is the co-founder and CEO of Renovia. He has over 25 years of experience in commercializing biotechnology, pharmaceuticals, and diagnostics. He has since successfully sealed a series of funding programs made to cater to different patients in the healthcare sector. Moreover, he has worked at ViaCell as the CEO. This is a biotechnology company that majors in the collection as well as the preservation of umbilical cord stem cells. Learn more: https://www.cnbc.com/video/2013/01/23/aegerion-ceo-on-promise-of-biopharma.html